Concepedia

Nicholas Buss

NB

12

Publications

518

Citations

12

H-Index

1999

Active since

Affiliations

Regenxbio (United States)(Current)

AstraZeneca (Germany)

Diabetes UK

Imperial College London Diabetes Centre

Imperial College London

Nicholas Buss is an author at Regenxbio (United States) specializing in medicine, cell biology, and neuroimmunology.

ORCID

Top concepts

Publications per year

1999–2023

12

Publications

12

AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression

Kun Ding, Jikui Shen, Zibran Hafiz et al. · Journal of Clinical Investigation · 2019 · 131 citations · Full text

, , +19

Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system

Felicity N. E. Gavins, Ellen L Hughes, Nicholas Buss et al. · The FASEB Journal · 2012 · 74 citations

Characterization of AAV-mediated dorsal root ganglionopathy

Nicholas Buss, Lisa G. Lanigan, Jillynne Zeller et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 69 citations · Full text

, , +17

Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein

Michael D. Oberst, Catherine Augé, Chad Morris et al. · Molecular Cancer Therapeutics · 2018 · 42 citations · Full text

The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects

J Michael Kilby, Andrew Hill, Nicholas Buss · HIV Medicine · 2002 · 36 citations · Full text

Rows per page

1–5 of 12